A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2002
11/19/2002	US6482517 Coated particles, methods of making and using
11/19/2002	US6482516 Enrobed tablet
11/19/2002	US6482491 Article having a surface showing adhesive properties
11/19/2002	US6482465 Positive hydration method of preparing confectionery and product therefrom
11/19/2002	US6482444 Silver-containing, sol/gel derived bioglass compositions
11/19/2002	US6482440 Long acting antidepressant microparticles
11/19/2002	US6482439 Drug delivery system exhibiting permeability control
11/19/2002	US6482438 Apparatus and process for preparing crystalline particles
11/19/2002	US6482437 Morphine sulfate microgranules, manufacturing process and pharmaceutical preparations
11/19/2002	US6482436 Magnetically responsive composition
11/19/2002	US6482435 Temperature sensitive gel for sustained delivery of protein drugs
11/19/2002	US6482434 Method for reducing adverse effects of a weight loss regimen
11/19/2002	US6482433 Instant foods, beverages
11/19/2002	US6482432 Extraction from plant; adding glycerin to maintain solution; water and alcohol removal; encapsulation in vegetable gelatin or hydroxypropyl methylcellulose
11/19/2002	US6482431 Method for application and maintenance of medication on body tissue
11/19/2002	US6482429 Stable powder inhalation dosage formulation
11/19/2002	US6482417 Stable pharmaceutical formulation comprising torsemide modification II
11/19/2002	US6482413 Vitamin B12 —biodegradable micro particulate conjugate carrier systems for peroral delivery of drugs, therapeutic peptides/proteins and vaccines
11/19/2002	US6482395 Chewing gum, lozenge, etc
11/19/2002	US6482390 Aerosol formulations and method
11/19/2002	US6481435 Closure-cap and container as a two-chamber cartridge for nebulizers for producing aerosols and active substance formulations, suitable for storage
11/19/2002	CA2332631C Soft gelatin capsule manufacture
11/19/2002	CA2281054C Combination of zinc ions and vitamin c and method of making
11/19/2002	CA2273026C Non-irritating cosmetic and pharmaceutical compositions
11/19/2002	CA2256896C Non-aqueous colonic purgative formulations
11/19/2002	CA2236422C Hydrolysis-optimized lipid emulsions and use thereof
11/19/2002	CA2227312C Nutraceutical antler powder and a method of producing same
11/19/2002	CA2219502C Methods and formulations for modulating the human sexual response
11/19/2002	CA2050970C Pharmaceutical compositions containing furan derivatives
11/18/2002	WO2001082979A1 Preparations for evaluating eliminative ability of stomach
11/18/2002	CA2409223A1 Preparations for evaluating eliminative ability of stomach
11/18/2002	CA2381637A1 Compositions and methods for treating or preventing convulsions or seizures
11/17/2002	CA2386649A1 Adhesive bandage
11/15/2002	CA2386430A1 Simethicone as weight gain enhancer
11/15/2002	CA2385782A1 Pharmaceutical composition for both intraoral and oral administration
11/14/2002	WO2002090510A2 Regulating immine responses using dendritic cells
11/14/2002	WO2002090313A1 Aloe-emodin derivatives and their use in the treatment of neoplastic pathologies
11/14/2002	WO2002090304A1 Stable solution of reduced coenzyme q
11/14/2002	WO2002090210A1 Packaging system for transdermal drug delivery systems
11/14/2002	WO2002090025A1 Mathod for preparing micro powder containing anti-agglomerated nanometer silver, micro powder produced by the mathod and its application
11/14/2002	WO2002089970A1 Process for the controlled production of organic particles
11/14/2002	WO2002089942A1 Formation of small crystals
11/14/2002	WO2002089916A1 Method of preventing type 2 diabetes with aerosolized insulin
11/14/2002	WO2002089868A1 Fibrin material and method for producing and using the same
11/14/2002	WO2002089854A1 Gene transfer of angiogenic factor for skin disease
11/14/2002	WO2002089850A1 Long acting antimicrobic preparation
11/14/2002	WO2002089849A1 Compositions and delivery systems for administration of a local anesthetic agent
11/14/2002	WO2002089846A1 Topical medication for burns and wounds
11/14/2002	WO2002089835A2 Pharmaceutical dosage form of amorphous nelfinavir mesylate
11/14/2002	WO2002089824A1 Combination of a gelatinase inhibitor and an anti-tumor agent, and uses thereof
11/14/2002	WO2002089823A1 Method of preserving foaming suppository
11/14/2002	WO2002089821A1 Ophthalmic liquid preparation and liquid preparation for contact lens
11/14/2002	WO2002089820A1 Formulation of amphiphilic heparin derivatives for enhancing mucosal absorption
11/14/2002	WO2002089818A1 Use of sucralfate for the treatment of cervical erosion
11/14/2002	WO2002089816A1 Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis
11/14/2002	WO2002089815A2 Disinfecting and solubilizing steroid compositions
11/14/2002	WO2002089796A2 Methods for selective immunomodulation using pimecrolimus
11/14/2002	WO2002089788A2 Pharmaceutical compositions comprising a hmg-coa reductase inhibitor
11/14/2002	WO2002089778A2 Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
11/14/2002	WO2002089777A1 Improved transdermal therapeutic system for the treatment of parkinson's disese
11/14/2002	WO2002089776A1 Nanoparticles made of protein with coupled apolipoprotein e for penetration of the blood-brain barrier and methods for the production thereof
11/14/2002	WO2002089775A1 Coated granules based on angiotensin-converting enzyme inhibitor
11/14/2002	WO2002089773A2 Pharmaceutical compositions comprising cyclosporin
11/14/2002	WO2002089772A1 Anti-angiogenic therapy using liposome-encapsulated chemotherapeutic agents
11/14/2002	WO2002089771A1 Liposomes
11/14/2002	WO2002089770A2 Topical lamellar double membrane structure composition containing n-acyl-ethanolamine and/or a quaternary ammonium salt and/or adenosylmethionine
11/14/2002	WO2002089769A2 Method for applying an active ingredient to a substrate, compositions for said method, container containing a composition and use of said compositions
11/14/2002	WO2002089768A1 Liquid injectable formulation of disodium pamidronate
11/14/2002	WO2002089767A1 Implantable drug delivery device and use thereof
11/14/2002	WO2002089764A2 Gelatin substitute
11/14/2002	WO2002089763A1 Pulse-release bolus
11/14/2002	WO2002089762A1 Concentrated w/o emulsion
11/14/2002	WO2002089751A1 System and method for intranasal administration of lorazepam
11/14/2002	WO2002089717A1 Patch applicator
11/14/2002	WO2002089715A1 Method for use in cataract surgery
11/14/2002	WO2002089699A2 Medical device and methods of use for glaucoma treatment
11/14/2002	WO2002089690A2 Dental composition for treating hypersensitive teeth
11/14/2002	WO2002089581A1 Antimicrobial compounds and methods for their use
11/14/2002	WO2002068562A9 Functionalized cubic liquid crystalline phase materials and methods for their preparation and use
11/14/2002	WO2002067831B1 Composition for freshening nostrils and sinus cavities
11/14/2002	WO2002062392A3 Water-soluble compositions of bioactive lipophilic compounds
11/14/2002	WO2002060339A3 Ophthalmic compositions for treating ocular hypertension
11/14/2002	WO2002056876A3 Treatment for snoring
11/14/2002	WO2002049623A3 Adhesive label with fluidifying agents for natural airway secretions
11/14/2002	WO2002045688A3 Composition for treatment of inflammatory disorders
11/14/2002	WO2002041875A3 Method for producing readily soluble medicament formulations and corresponding formulations
11/14/2002	WO2001024839A9 Silver-containing compositions, devices and methods for making
11/14/2002	WO2001011009A9 Intestinal gene therapy
11/14/2002	US20020169476 Method for hemostasis
11/14/2002	US20020169439 Modular infusion device and method
11/14/2002	US20020169410 Brachytherapy apparatus and methods
11/14/2002	US20020169310 Subjecting carrageenan-containing seaweed material having solids content of less than 25% by weight to shear stress treatment; for foods, dairy products, toothpaste
11/14/2002	US20020169212 A readily water-soluble ingestible form of ketoprofen formed by the reaction with any edible weak base to yield a palatable, stable, safe solution and including an sweetener for flavor; feeds; veterinary medicine
11/14/2002	US20020169211 Magnesium di-potassium EDTA complex and method of administration
11/14/2002	US20020169199 Ready-to-inject; buffer with pH of 7.2 to 4.0, a water-soluble organic solvent, an antioxidant and an agent which binds heavy metal ions
11/14/2002	US20020169190 Dosing schedule of antitumor agents
11/14/2002	US20020169181 Arylglycinamide derivatives
11/14/2002	US20020169168 Pharmaceutical formulations of ciprofloxacin
11/14/2002	US20020169162 Device and method for treating conditions of a joint
11/14/2002	US20020169152 Methods for treating stress disorders using glucocorticoid receptor-specific antagonists

1 ... 2211 2212 2213 2214 2215 2216 2217 2218 2219 2220 2221 2222 2223 2224 2225 2226 2227 2228 2229 2230 2231 ... 2991